Author

A. Rudiger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

C. Cervia· 3 shared J. Nilsson· 3 shared L. C. Huber· 3 shared O. Boyman· 3 shared S. Adamo· 3 shared Y. Zurbuchen· 3 shared A. Jacobs· 2 shared B. Bodenmiller· 2 shared

Activity by Year

2020-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

C. Cervia

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A distinct innate immune signature marks progression from mild to severe COVID-19

S. Chevrier, Y. Zurbuchen, C. Cervia, S. Adamo, M. E. Raeber, N. de Souza, S. Sivapatham, A. Jacobs, E. Bächli, A. Rudiger, M. Stüssi-Helbling, L. C. Huber, D. J. Schaer, J. Nilsson, O. Boyman, B. Bodenmiller

The paper identifies an innate immune signature associated with progression from mild to severe COVID-19 using mass cytometry and proteomics.

bioRxiv · Aug 4, 2020Immunology

Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19

S. Adamo, S. Chevrier, C. Cervia, Y. Zurbuchen, M. E. Räber, L. Yang, S. Sivapatham, A. Jacobs, E. Bächli, A. Rudiger, M. Stüssi-Helbling, L. C. Huber, D. Schaer, B. Bodenmiller, O. Boyman, J. Nilsson

This study identifies T cell apoptosis and migration as mechanisms of peripheral T cell lymphopenia in severe COVID-19 and links lymphopenia to subsequent T cell proliferation.

bioRxiv · Aug 4, 2020 · PreprintImmunology

Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19

C. Cervia, J. Nilsson, Y. Zurbuchen, A. Valaperti, J. Schreiner, A. Wolfensberger, M. E. Raeber, S. Adamo, M. Emmenegger, S. Hasler, P. P. Bosshard, E. De Cecco, E. Baechli, A. Rudiger, M. Stuessi-Helbling, , O. Boyman

This study compares SARS-CoV-2-specific antibody responses in mild and severe COVID-19 patients and healthcare workers, finding higher systemic IgA and IgG in severe cases and mucosal IgA in asymptomatic exposed individuals.

bioRxiv · May 21, 2020Immunology